CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics (“Aviceda”), a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Elumn8 Medical, Inc., formerly known as Simpson Interventions, today announced the successful initial close of its Series C financing and the company’s rebrand to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results